SCHEMBL6501829

SCHEMBL6501829

CC(N)c1cccc(C2CCN(C(=O)c3cncc(CCc4ccccc4)c3)CC2)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 4/20 0.42
PARP1 P09874 1/20 0.42
MGLL Q99685 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CCR5 P51681 1/20 0.40
PARP14 Q460N5 1/20 0.39
PARP10 Q53GL7 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7107726 0.99 TPSAB1 (0.41) TPSAB1PARP1MGLLCA12CA1
Hydrochloric Acid SCHEMBL4399047 0.99 TPSAB1 (0.41) TPSAB1PARP1MGLLCA12CA1
SCHEMBL7026391 0.86 CA12 (0.42) TPSAB1MGLLCA12CA1CA2
SCHEMBL7021172 0.85 TPSAB1 (0.53) TPSAB1
Hydrochloric Acid SCHEMBL4399044 0.85 CA12 (0.41) TPSAB1MGLLCA12CA1CA2
SCHEMBL7018734 0.85 TPSAB1 (0.46) TPSAB1PARP1CA12CA1CA2
Hydrochloric Acid SCHEMBL4402047 0.85 TPSAB1 (0.52) TPSAB1
SCHEMBL1872130 0.83 HPN (0.47) PARP1CA12CA1CA2CA7
Hydrochloric Acid SCHEMBL27517324 0.83 MGLL (0.39) MGLLCA12CA1CA2CA7
Hydrochloric Acid SCHEMBL1867557 0.82 HPN (0.46) PARP1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6977263-B2 Chemical compounds AVENTIS PHARMACEUTICALS INC. (US) 2005-12-20 US disclosed
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed